Compare OPAD & PLSM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | OPAD | PLSM |
|---|---|---|
| Founded | 2015 | 2014 |
| Country | United States | Israel |
| Employees | N/A | N/A |
| Industry | Real Estate | Medical/Dental Instruments |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 24.5M | 22.3M |
| IPO Year | 2020 | 2025 |
| Metric | OPAD | PLSM |
|---|---|---|
| Price | $4.57 | $3.41 |
| Analyst Decision | Buy | |
| Analyst Count | 4 | 0 |
| Target Price | ★ $1.83 | N/A |
| AVG Volume (30 Days) | 46.5K | ★ 54.6K |
| Earning Date | 04-30-2026 | 03-30-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 33.92 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $567,812,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $32.08 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $0.54 | $2.88 |
| 52 Week High | $6.35 | $12.97 |
| Indicator | OPAD | PLSM |
|---|---|---|
| Relative Strength Index (RSI) | 50.50 | 37.99 |
| Support Level | $4.44 | N/A |
| Resistance Level | $5.51 | $3.82 |
| Average True Range (ATR) | 0.48 | 0.25 |
| MACD | -0.00 | -0.01 |
| Stochastic Oscillator | 63.35 | 27.38 |
Offerpad Solutions Inc provides a way to buy and sell a home. It uses technology-enabled solutions to remake the home selling and buying experience by offering customers the convenience, control, and certainty to solve their housing needs. It combines fundamental real estate expertise with the data-driven digital Solutions Center platform to efficiently sell and buy their homes online with streamlined access to other services, including mortgage, listing, renovation, and buyer representation services.
Pulsenmore Ltd is an emerging medical device company engaged in the research, development, manufacturing, marketing, and sale of non-invasive portable ultrasound solutions for home use. Its products include the Pulsenmore ES and Pulsenmore FC, along with the early-stage Pulsenmore MC, collectively referred to as Pulsenmore Products, enabling remote ultrasound scans in gynecology and other fields such as pulmonary, cardiology, and urology through telemedicine. The Company operates in a single segment focused on developing and commercializing portable ultrasound technologies, with Israel contributing the majority of its revenue.